The EVO study protocol for a randomized controlled evaluation trial of an optimized weight management intervention.

BACKGROUND: Obesity is a substantial public health concern; however, gold-standard behavioral treatments for obesity are costly and burdensome. Existing adaptations to the efficacious Diabetes Prevention Program (DPP) demonstrate mixed results. Our prior research applying the Multiphase Optimization Strategy (MOST) to DPP identifies a more parsimonious, less costly intervention (EVO) resulting in significant weight loss. OBJECTIVE: The aim of the remotely conducted EVO trial is to test the non-inferiority of EVO against DPP. We will conduct economic evaluations alongside the trial to estimate delivery and patient costs, cost-effectiveness, and lifetime healthcare costs of EVO as compared to DPP. Exploratory analyses will examine maintenance, moderators, and mediators of the treatment effect. STUDY DESIGN: The EVO trial will recruit nationally to randomize 524 participants with obesity. Participants will receive either EVO or DPP over a 6 month period. EVO participants will be provided online lessons, a smartphone application to self-monitor diet, physical activity, and weight, and attend 12 brief calls with a Health Promotionist. DPP participants will receive the first 6 months of the Center for Disease Control's T2D materials and attend 16 one-hour video call sessions with staff certified in DPP delivery. Weight will be measured at baseline, 3-, 6-, and 12-months. Itemized delivery cost will be collected. Staff and participants will also provide information to estimate costs for intervention-related activities. SIGNIFICANCE: The EVO trial could establish evidence supporting dissemination of a scalable, cost-effective behavioral treatment with potential to shift clinical practice guidelines, inform policy, and reduce the prevalence of obesity.

Multisegment foot kinematics during walking in younger and older adults.

BACKGROUND: Currently, age-related changes in foot mechanics are poorly understood. A greater understanding of the natural changes in foot motion is needed to improve our understanding of pathological foot conditions. METHODS: The purpose of this study was to compare multisegment foot kinematic data during gait in younger and older individuals. Eleven (N = 11) adult male participants between the ages of 18 - 30 years (younger group; mean ± SD: 24.6 ± 3.0 years) and eleven (N = 11) adults aged 55 years or older (older group; mean ± SD: 65.0 ± 4.2 years) were recruited for the study. The foot was modeled as a four-segment rigid body model. Three-dimensional kinematic and kinetic gait parameters were recorded using an 8-camera Vicon MCam motion capture system and two Kistler force plates. A MANOVA was used to test for significant differences in mean temporal-spatial data, mean ranges of motion, and mean peak joint angle data between age groups. RESULTS: No significant differences (P > 0.05) were found between the two age groups for any of the gait parameters. The results of the present study suggest that individuals aged 65.0 ± 4.2 years have foot mechanics that are comparable to younger walkers. CONCLUSIONS: As such, any deviations in motion at this age may be indicative of an underlying disease or disorder.